DFFN Diffusion Pharmaceuticals Inc
Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy.
$0.90
As of 03/05/2021 IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
08/11/2005
101,677,093
17,635,284
$91,123,011
0.00%
SEC Edgar Online
10-Q
10-K
253748206
US2537482067
BD0YGB5
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
08/11/2005
101,677,093
17,635,284
$91,123,011
0.00%
SEC Edgar Online
10-Q
10-K
253748206
US2537482067
BD0YGB5
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
3.17
0.00
-48.30%
0.00%
3.17
0.00
-48.30%
0.00%